NCT00346853View on ClinicalTrials.gov

Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

September 30, 2006

Conditions
Macular Dystrophy, Corneal
Interventions
DRUG

4-Methylpyrazole

15 mg/kg dose

OTHER

saline

Trial Locations (1)

84132

Moran Eye Center, University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT00346853 - Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy | Biotech Hunter | Biotech Hunter